Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content
This peptide is a newer player in the realm of peptide therapies
Common Side Effects: Clinical trials involving approximately 900 participants indicate that AOD-9604 is generally well-tolerated with a favorable safety profile
Pregnant or breastfeeding women safety unknown Cancer patients or those with tumor history due to VEGF promotion, angiogenesis could theoretically support tumor growth Autoimmune disorders while BPC-157 is generally anti-inflammatory, immune modulation can vary by individual Angiogenic peptides may pose theoretical risks in neoplastic conditions by promoting blood vessel formation
The speed at which B12 treats nerve symptoms shows differences between patients
Beyond mouth ulcers, patients may experience: A sore, red, or swollen tongue (glossitis) Burning sensation in the mouth Altered taste perception Angular cheilitis (cracks at the corners of the mouth) Haematological manifestations arise from impaired red blood cell production
